CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing C... CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Show more
SINGAPORE, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Further to an announcement on October 7, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based...
SINGAPORE, Oct. 07, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...
SINGAPORE, Oct. 03, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...
Conference call via Zoom is scheduled for October 8, 2024 at 9 a.m. ET (9 p.m. SGT) https://us06web.zoom.us/meeting/register/tZMrcOmppj0sGdA37lASywTyixRflo9w1TZT SINGAPORE, Sept. 30, 2024...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.62 | 27.1929824561 | 2.28 | 3.35 | 2.1 | 56907 | 3.03822828 | CS |
4 | 0.37 | 14.6245059289 | 2.53 | 3.35 | 1.8302 | 18504 | 2.84219004 | CS |
12 | 1.41 | 94.6308724832 | 1.49 | 3.56 | 1.2 | 17515 | 2.53995757 | CS |
26 | 0.86 | 42.1568627451 | 2.04 | 3.56 | 1.2 | 41436 | 2.26755458 | CS |
52 | -0.67 | -18.7675070028 | 3.57 | 5.5 | 1.2 | 36091 | 2.89875919 | CS |
156 | -1.1 | -27.5 | 4 | 9.25 | 1.2 | 106399 | 4.48816879 | CS |
260 | -1.1 | -27.5 | 4 | 9.25 | 1.2 | 106399 | 4.48816879 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.